CompletedNot Applicable

Low Fat-free Mass in Prognosis of People With Chronic Obstructive Pulmonary Disease

Egypt90 participantsStarted 2024-04-01

Plain-language summary

The effects of low fat-free mass in Prognosis of people with chronic obstructive pulmonary disease (COPD) as regard clinical evaluation using BODE index, GOLD ABE assessment ( Gold 2024 ) functional evaluation using spirometry and 6 min walk test and radiological evaluation by computed chest tomography.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Were adults aged ≥40 years with a clinical diagnosis of COPD confirmed by spirometry showing post-bronchodilator FEV₁/FVC \<0.70 according to GOLD 2024 criteria Exclusion Criteria: * Exacerbation within the preceding month, active pulmonary infection, physical disability precluding study measurements (e.g., musculoskeletal or neurological disorders), advanced heart failure (NYHA class III-IV), malignancy or hyperthyroidism.

What they're measuring

Fat-free Mass in Chronic Obstructive Pulmonary Disease

Timeframe: 6 months

Trial details

NCT IDNCT07541053

SponsorMansoura University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease (COPD) trials